Institutes at BioPark

AARU Audi Accident Research Unit

With the joint goal of reducing the risk of injuries and its consequences, AUDI AG and the department of casualty surgery at the University of Regensburg have joined forces in a research project called AARU (AUDI ACCIDENT RESEARCH UNIT).

Fraunhofer ITEM

Currently, one in four deaths is caused by cancer – mainly as a result of metastatic disease spread. Thus, the Project Group concentrates on the development of diagnostic tests to detect disseminated cancer cells early in the disease and to predict the response to therapy of metastatic progenitor cells.

Institute of functional genomics

Systems biology of malignant and non-malignant diseases; Development of analytical tools for the high-throughput systematic characterization of genomes, transcriptomes, proteomes and metabolomes of cells, tissues and biofluids; Structural, functional and comparative genomics


Recent advances in Microarray and Deep Sequencing Technologies fundamentally changed the face of modern life sciences. Within this vibrant and constantly growing market, KFB - Center of Excellence for Fluorescent Bioanalytics - has established itself as a competent service provider offering customer-oriented research and development solutions.

Labor für Experimentelle Unfallchirurgie (Klinik und Poliklinik für Unfallchirurgie)

The Laboratory of Experimental Trauma Surgery investigates the basics and coherence of joint diseases and connective tissues.


The “Regensburg Center of Biomedical Engineering” (RCBE) is an inter-faculty and inter-university research institute of the Ostbayerische Technische Hochschule Regensburg (OTH Regensburg) and the Regensburg University (UR).


The “Regensburg Center of Health Sciences and Technology” (RCHST) is an inter-faculty research institute at the Ostbayerische Technische Hochschule Regensburg (OTH Regensburg), which is substantially supported by the Bavarian State Government.

RCI Regensburg Center for Interventional Immunology

The RCI Regensburg Center for Interventional Immunology was established in 2010 as a central unit of Regensburg University in order to tie all academic research areas related to the development of new immunotherapies.


The establishment of the “Center for Medical Biotechnology” focuses the University activities in the area of Tissue Engineering, cartilage, bone and tumor research. Scientists and clinicians from three different clinical disciplines (Maxillofacial Surgery, Orthopedic Surgery, Trauma Surgery) work together on different aspects of Tissue Engineering with emphasis on regenerative therapy and understanding of pathologies of the musculoskeletal systems.